RESUMO
The aim of our research was to evaluate the structure and the determination of the phenotypes of antibiotic resistance of microflora isolated from patients' blood in a multidisciplinary hospital during the period from 2013 to 2017. The material was taken into BacT / ALERT bottles containing nutrient media, followed by incubation of blood. In case of a positive result, the material from the vials was dispersed into dense nutrient media. Species identification was carried out using commercial biochemical API test systems and MALDITOF mass spectrometry. The antibiotic resistance of the isolated microorganisms was evaluated by a classical disc-diffusion method. From 2013 to 2017, 3504 blood tests were performed, of which 16.8% were positive. Of the isolated strains, 69.6% were Gram-positive, 27% were Gram-negative, and 3.4% were fungi. The structure of Gram-positive bacteria included Staphylococcus spp - 71.46%, Enterococcus spp. - 21.22% and Streptococcus spp - 7.32%. Staphylococcus aureus (47,8%) prevailed among staphylococci (in 62.14% were methicillin-resistant) and coagulase-negative staphylococci. Among the genus Enterococcus spp, Enterococcus faecalis prevailed (27% resistant to macrolides, 14% to fluoroquinolones) and Enterococcus faecium (69% resistant to penicillins, fluoroquinolones, macrolides). Streptococcus pneumoniae, Streptococcus pyogenes and streptococci from the group of alpha-greening were isolated from streptococci. Clinically significant types of streptococci in 33.3% were resistant to macrolides and fluoroquinolones. In the structure of gram-negative bacteria, Enterobacteriaceae prevailed - 71.07% (Klebsiella pneumoniae, E. coli); the proportion of non-fermenting Gram-negative bacteria (NFGOB) was 28.93%. Most Gram-negative bacteria were producers of extended-spectrum beta-lactamases (BLBRs). In NFGOB structure allocated Acinetobacter baumanii - 56,5% (81% polyresistant), Pseudomonas aeruginosa - 30,4% (50% - Carbapenemase Producing Organisms), Stenotrophomonas maltophilia - 10,9%. Thus, microbiological research in septic blood conditions is an integral part of the diagnostic search, selection of etiotropic therapy and monitoring of its effectiveness.
